Monopar Therapeutics Inc. MNPR
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Monopar Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel radiopharmaceuticals for oncology and treatments for rare diseases such as Wilson Disease. The company’s pipeline includes advanced radiopharmaceutical candidates designed to target solid tumors for both imaging and therapeu…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees22
TickerMNPR
Statistics
Market Cap$429.6M
Revenue (TTM)$0
Net Income-$13.7M
Net Margin—
EPS$-1.93
P/E-31.83
P/S—
P/B2.87
EV/EBITDA-15.61
ROE-15.9%
Dividend Yield—
Price$64.13
Data: Twelve Data · Revenue = mcap / P/S